JAMA Oncology (journal)

September 5, 2019

Study backs genetic testing for all metastatic breast cancer patients

By Tom Wilemon

June 27, 2019

Health disparity for black people exists within lung screening guidelines

By Tom Wilemon

November 15, 2018

Immunotherapies linked to specific heart complications

In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis and arrhythmias, and that they occur early in the course of treatment.

By Tom Wilemon

September 13, 2018

Study tracks incidence, timing of immunotherapy-related deaths

Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

By Tom Wilemon

February 26, 2015

Cancer survival improvements vary by age, race

Improvements in cancer diagnosis and treatment have led to longer survival for most cancer patients in the United States. However, the improvement in survival was substantially greater among younger patients and those who are white in most of the cancers studied, according to new research by Vanderbilt University investigators.

By VUMC News and Communications